Glenmede Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,689
| Closed | -$307K | – | 1383 |
|
|
2023
Q2 | $307K | Hold |
1,689
| – | – | ﹤0.01% | 985 |
|
|
2023
Q1 | $307K | Sell |
1,689
-653
| -28% | -$119K | ﹤0.01% | 990 |
|
|
2022
Q4 | $460K | Buy |
2,342
+292
| +14% | +$57.4K | ﹤0.01% | 853 |
|
|
2022
Q3 | $461K | Sell |
2,050
-648
| -24% | -$146K | ﹤0.01% | 838 |
|
|
2022
Q2 | $341K | Buy |
+2,698
| New | +$341K | ﹤0.01% | 967 |
|
|
2021
Q1 | – | Sell |
-2,590
| Closed | -$263K | – | 1267 |
|
|
2020
Q4 | $263K | Sell |
2,590
-1,130
| -30% | -$115K | ﹤0.01% | 1000 |
|
|
2020
Q3 | $287K | Buy |
3,720
+935
| +34% | +$72.1K | ﹤0.01% | 935 |
|
|
2020
Q2 | $310K | Buy |
2,785
+595
| +27% | +$66.2K | ﹤0.01% | 896 |
|
|
2020
Q1 | $164K | Hold |
2,190
| – | – | ﹤0.01% | 1261 |
|
|
2019
Q4 | $164K | Buy |
+2,190
| New | +$164K | ﹤0.01% | 1261 |
|